Alexander O. Schuth - Feb 8, 2024 Form 4 Insider Report for Denali Therapeutics Inc. (DNLI)

Role
COFO and Secretary
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Feb 8, 2024
Transactions value $
$34,000
Form type
4
Date filed
2/12/2024, 04:48 PM
Previous filing
Jan 9, 2024
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Options Exercise $34K +50K +31.21% $0.68* 210K Feb 8, 2024 Direct F1, F2
holding DNLI Common Stock 524K Feb 8, 2024 See footnote F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNLI Stock Option (right to buy) Options Exercise $0 -50K -25.63% $0.00 145K Feb 8, 2024 Common Stock 50K $0.68 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 136,721 RSUs.
F2 Reflects 15,558 shares previously disclosed as held indirectly; but have been determined to be held directly.
F3 The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
F4 The vesting of the shares subject to the option are contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on March 3, 2021, and 50% of the shares subject to the option will vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days.